J&J(US:JNJ) Mei Ri Jing Ji Xin Wen·2025-10-08 15:54Core Viewpoint - Johnson & Johnson has been ordered by a jury to pay $966 million in damages to the family of a woman who died from mesothelioma, linking the cancer to the company's talc products [1][2]. Group 1: Legal Proceedings - The jury awarded $16 million in compensatory damages and $950 million in punitive damages, although the punitive amount may be reduced upon appeal [1]. - Johnson & Johnson plans to appeal the decision, claiming it is "extreme and unconstitutional" and alleging that the plaintiff's lawyers used "junk science" in their arguments [1][2]. - The company has faced over 67,000 lawsuits related to its talc products, with most claims associated with ovarian cancer rather than mesothelioma [2]. Group 2: Company Response and Market Reaction - Johnson & Johnson maintains that its products are safe, asbestos-free, and do not cause cancer, having ceased sales of talc-based baby powder in the U.S. in 2020 [1][2]. - Following the jury's decision, Johnson & Johnson's stock showed minimal reaction, closing up 0.39% on October 7 and slightly fluctuating thereafter, with a current share price of $188.965 and a market capitalization of $455.1 billion [2].